Facebook Linkedin RSS Twitter Youtube
Home 2024

Clinical drug development

Transgene and ProBioGen Collaborate on Individualized Cancer Vaccine Development
Bioprocessing

Transgene and ProBioGen Collaborate on Individualized Cancer Vaccine Development

Baker Lab’s AI-Driven Antibody Cage Technology Unlocked as Archon Biosciences
Artificial Intelligence

Baker Lab’s AI-Driven Antibody Cage Technology Unlocked as Archon Biosciences

Effects of Mutations on Protein-Protein Interactions Predicted by New AI Tool
Artificial Intelligence

Effects of Mutations on Protein-Protein Interactions Predicted by New AI Tool

Recursion’s Fast-Track Road to Therapeutics Using AI-Based Maps of Biology
Artificial Intelligence

Recursion’s Fast-Track Road to Therapeutics Using AI-Based Maps of Biology

Hubble Therapeutics Taps Andelyn to Manufacture Clinical Grade AAV for Eye Disorder Gene Therapy
Bioprocessing

Hubble Therapeutics Taps Andelyn to Manufacture Clinical Grade AAV for Eye Disorder Gene Therapy

Multi-Drug Resistant TB Tackled with Plant-Derived Compound in Preclinical Study
Drug Discovery

Multi-Drug Resistant TB Tackled with Plant-Derived Compound in Preclinical Study

AI in Drug Design: From Hype to Real-World Results
Artificial Intelligence

AI in Drug Design: From Hype to Real-World Results

Quell Therapeutics Taps eXmoor Pharma to Manufacture CAR-Tregs
Bioprocessing

Quell Therapeutics Taps eXmoor Pharma to Manufacture CAR-Tregs

MinervaX and Wacker Collaborate on Manufacturing Prophylactic Group B Streptococcus Vaccine
Bioprocessing

MinervaX and Wacker Collaborate on Manufacturing Prophylactic Group B Streptococcus Vaccine

Positive Phase II Bolsters Aura Bioscience’s Confidence in VDC-based Therapy for Ocular Melanomas
Cancer

Positive Phase II Bolsters Aura Bioscience’s Confidence in VDC-based Therapy for Ocular Melanomas

123...206Page 1 of 206
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.